CFLT · As filed with the SEC
Confluent balance sheet, by quarter
The statement as Confluent presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
Consolidated Balance Sheets · USD thousands
| USD thousands | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 |
|---|---|---|---|---|
| ASSETS | ||||
| Current assets: | ||||
| Cash and cash equivalents | 347,210 | 298,537 | 295,591 | 278,561 |
| Marketable securities | 1,706,762 | 1,691,241 | 1,645,032 | 1,638,016 |
| Accounts receivable, net | 390,752 | 356,397 | 357,607 | 297,862 |
| Deferred contract acquisition costs | 54,545 | 49,814 | 47,658 | 46,149 |
| Prepaid expenses and other current assets | 107,744 | 102,869 | 95,606 | 82,250 |
| Total current assets | 2,607,013 | 2,498,858 | 2,441,494 | 2,342,838 |
| Property and equipment, net | 93,179 | 89,260 | 86,962 | 81,697 |
| Operating lease right-of-use assets | 4,936 | 5,791 | 6,932 | 7,923 |
| Goodwill | 164,406 | 164,406 | 164,406 | 164,406 |
| Intangible assets, net | 6,054 | 6,525 | 6,997 | 7,463 |
| Deferred contract acquisition costs, non-current | 77,737 | 70,548 | 68,473 | 69,069 |
| Other assets, non-current | 31,945 | 41,717 | 42,144 | 25,278 |
| Total assets | 2,985,270 | 2,877,105 | 2,817,408 | 2,698,674 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||
| Current liabilities: | ||||
| Accounts payable | 20,708 | 11,765 | 11,491 | 5,983 |
| Accrued expenses and other liabilities | 182,735 | 154,441 | 167,839 | 141,922 |
| Operating lease liabilities | 8,178 | 9,393 | 9,251 | 9,093 |
| Deferred revenue | 468,984 | 447,012 | 424,293 | 372,870 |
| Total current liabilities | 680,605 | 622,611 | 612,874 | 529,868 |
| Operating lease liabilities, non-current | 1,205 | 2,064 | 4,454 | 6,735 |
| Deferred revenue, non-current | 29,655 | 28,251 | 31,356 | 32,511 |
| Convertible senior notes, net | 1,095,988 | 1,095,019 | 1,094,051 | 1,093,094 |
| Other liabilities, non-current | 8,678 | 10,210 | 11,006 | 11,133 |
| Total liabilities | 1,816,131 | 1,758,155 | 1,753,741 | 1,673,341 |
| Stockholders’ equity: | ||||
| Preferred stock, par value of $0.00001 per share; 10,000 shares authorized as of December 31, 2025 and December 31, 2024; 0 shares issued and outstanding as of December 31, 2025 and December 31, 2024 | 0 | 0 | 0 | 0 |
| Class A Common Stock | 3 | 3 | 2 | 2 |
| Class B Common Stock | 1 | 1 | 1 | 1 |
| Additional paid-in capital | 3,447,970 | 3,317,956 | 3,192,349 | 3,079,260 |
| Accumulated other comprehensive income (loss) | 5,656 | 6,234 | 10,055 | 2,860 |
| Accumulated deficit | (2,284,491) | (2,205,244) | (2,138,740) | (2,056,790) |
| Total stockholders’ equity | 1,169,139 | 1,118,950 | 1,063,667 | 1,025,333 |
| Total liabilities and stockholders’ equity | 2,985,270 | 2,877,105 | 2,817,408 | 2,698,674 |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.